Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Netherlands Pharmaceutical Pricing & Reimbursement Guide 2016 - Research and Markets

Research and Markets
Posted on: 05 Oct 16

Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Netherlands" report to their offering.

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Key Topics Covered:

1. HEALTHCARE SYSTEM

Facts & Figures

Market Indicators

Provision & Funding

Basic Health Insurance

Supplementary Health Insurance

Long-term Care

2. PRICING

Prescription Drugs

WGP Methodology

WGP Price Revisions

Pricing Agreements

Generic Drugs

Hospital Drugs

Pricing Rules

Price Negotiations and Tendering

Controversy over Hospital Medicines Prices

Joint Purchasing Schemes

Cross-border Procurement

OTC Drugs

3. REIMBURSEMENT

Admission to Reimbursement

Pre-assessment Process

Reimbursement Applications

Assessment

Decision

Appeals

Provisional Reimbursement

Barriers to Access

Reassessments

Changes in Reimbursement Prices

4. PHARMACOECONOMICS

Pharmacoeconomic Requirements

Mandatory Requirement

Exemptions

Pharmacoeconomic Guidelines

Proposed QALY Threshold

Hospital Drugs

Orphan Drugs

Provisional Reimbursement

5. PRICE BUILD UP

Retail Pharmacies

Pharmacy Remuneration

Discounts

Clawback System

Pharmacy Chains

OTC Sales

E-pharmacy

Supply Shortages

Dispensing Doctors

Sales Tax

6. COST CONTAINMENT

Industry Paybacks

Promotional Costs

Patient Co-payments

Deductible

Other Charges for Prescription Medicines

Prescribing Controls

Treatment Guidelines

Targets

7. FUTURE DEVELOPMENTS

Outlook

Drug Pricing

Medicines Policy Plan

Cross-border Co-operation

Cost-effectiveness Threshold

8. NAMES & ADDRESSES

For more information about this report visit http://www.researchandmarkets.com/research/bxn3fj/ims

View source version on businesswire.com: http://www.businesswire.com/news/home/20161005006076/en/

Business Wire
www.businesswire.com

Last updated on: 05/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.